Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

3.08
Delayed Data
As of Sep 20
 0.00 / 0.00%
Today’s Change
2.61
Today|||52-Week Range
8.40
-47.42%
Year-to-Date
Institutional investors purchased a net $3.9 thousand shares of NVGN during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 1.59% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Other institutional1.59%
Mutual fund holders0.00%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

6/30/2017MORGAN STANLEY & CO. LLC  Bought 5.1 Thousand shares of Novogen Ltd
6/30/2017CITADEL ADVISORS LLC  Bought 1.3 Thousand shares of Novogen Ltd
6/30/2017MARKETOCRACY CAPITAL MANAGEMENT ...  Sold 200.00 shares of Novogen Ltd

Top 10 Owners of Novogen Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Morgan Stanley & Co. LLC0.75%36,275109,551+5,125+16.45%
Renaissance Technologies LLC0.71%34,325103,66200.00%
Citadel Advisors LLC0.09%4,52413,662+1,336+41.91%
RBC Capital Markets LLC (Investme...0.03%1,2503,77500.00%
UBS Securities LLC0.01%307927-1,720-84.85%
UBS Financial Services, Inc.0.00%20963100.00%
Creative Planning, Inc.0.00%5015100.00%
Merrill Lynch, Pierce, Fenner & S...0.00%5516600.00%
Morgan Stanley Smith Barney LLC (...0.00%00-681-100.00%
Marketocracy Capital Management L...0.00%00-200-100.00%

Top 10 Mutual Funds Holding Novogen Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Marketocracy Masters 100 Fund0.00%00-200-100.00%